American Society of Clinical Oncology
Founded in 1964, the American Society of Clinical Oncology (ASCO) is the world’s leading professional organization for physicians and oncology professionals caring for people with cancer. Its mission is to conquer cancer through research, education, and promotion of the highest quality patient care. ASCO’s diverse network of more than 40,000 oncology professionals recognizes ASCO’s dedication to provide the highest-quality resources in education, policy, the pioneering of clinical research, and. above all, advancing the care for patients with cancer. ASCO is unique in that we are the only organization that encompasses all oncology subspecialties, allowing our members to grow from the professional and personal expertise of their colleagues worldwide and across disciplines.
Cancer Drug Development Form
The Cancer Drug Development Forum (CDDF) is a non-profit organisation registered in Belgium that provides a neutral platform to stimulate interaction between stakeholders involved in cancer drug development.
The CDDF’s mission is to facilitate collaboration between stakeholders, to increase efficiency in cancer drug development and accelerate the delivery of effective oncology treatment to patients.
Its integrative approach brings together leading voices from academia, the pharmaceutical industry, regulatory authorities, policymakers and patient advocacy groups to improve cancer treatment.
HISTORY
Established in 2001 as the Biotherapy Development Association (BDA), the initial focus of the organisation was immunotherapy. In recognition of the importance of embracing all forms of oncology drug development, the association changed its name to the Cancer Drug Development Forum (CDDF) in 2014.
This new name clearly represents CDDF’s mission to facilitate an exchange of experience from all parties dedicated to developing cancer drugs and delivering effective treatment to patients.